A new method for post Genome-Wide Association Study (GWAS) analysis of colorectal cancer in Taiwan

Gene

Volumn 518, Issue 1, 2013, Pages 107-113

  Wang, Hwei Ming ^a   Chang, Tzu Hao ^b   Lin, Feng Mao ^c   Chao, Te Hsin ^a   Huang, Wei Chih ^c   Liang, Chao ^c   Chu, Chao Fang ^c   Chiu, Chih Min ^c   Wu, Wei Yun ^c   Chen, Ming Cheng ^a   Weng, Chen Tsung ^d   Weng, Shun Long ^c,e,f,g   Chiang, Feng Fan ^a   Huang, Hsien Da ^c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d Health GeneTech Corporation   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^g MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

Colorectal cancer; Genome Wide Association Studies; GWAS; Risk prediction; Single nucleotide polymorphism; SNP

Indexed keywords

ANALYSIS OF VARIANCE; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BIOINFORMATICS; CANCER RISK; CANCER SUSCEPTIBILITY; CELIAC DISEASE; COLORECTAL CANCER; CONTROLLED STUDY; EUROPEAN AMERICAN; GENE REPLICATION; GENETIC ASSOCIATION; HUMAN; IMMUNOREGULATION; INFORMATION RETRIEVAL; OBESITY; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TAIWAN;

EID: 84875373861     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.067     Document Type: Article

References (70)

1. Aaltonen L., et al. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin. Cancer Res. 2007, 13(1):356-361.
2. Abnet C.C., et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 2010, 42(9):764-767.
3. Anand P., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008, 25(9):2097-2116.
4. Anjos S., et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J. Biol. Chem. 2002, 277(48):46478-46486.
5. Bai Y., et al. Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study. BMC Cancer 2007, 7:81.
6. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545.
7. Barry K.H., et al. Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk. Environ. Health Perspect. 2011, 119(12):1726-1732.
8. Bei J.X., et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet. 2010, 42(7):599-603.
9. Brophy K., et al. Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study. BMC. Med. Genet. 2010, 11:76.
10. Chen H.H., Lee W.J., Fann C.S., Bouchard C., Pan W.H. Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese. Am. J. Clin. Nutr. 2009, 90:255-262.
11. Chistyakov D.A., et al. Complex association analysis of graves disease using a set of polymorphic markers. Mol. Genet. Metab. 2000, 70(3):214-218.
12. Commins S., et al. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J. Allergy Clin. Immunol. 2008, 121(5):1108-1111.
13. de Bouteiller O., et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J. Biol. Chem. 2005, 280(46):38133-38145.
14. Dittmer S., et al. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J. Cell Sci. 2011, 124(Pt 2):252-260.
15. Eby M.T., et al. TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J. Biol. Chem. 2000, 275(20):15336-15342.
16. Eeles R.A., et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 2008, 40(3):316-321.
17. Ferlay J.S.H., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide:IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer (accessed on 1/7/2012). http://globocan.iarc.fr.
18. Gionet N., et al. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. J. Cell. Biochem. 2009, 107(3):448-459.
19. Goldacre M.J., et al. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study. Eur. J. Gastroenterol. Hepatol. 2008, 20(4):297-304.
20. Grazia Lampugnani M., et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 2003, 161(4):793-804.
21. Haiman C.A., et al. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet. 2007, 39(8):954-956.
22. Hao B., et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004, 64(12):4378-4384.
23. He J.F., et al. Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 2007, 7:194.
24. Houlston R.S., et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat. Genet. 2008, 40(12):1426-1435.
25. Hsiung C.A., et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 2010, 6(8).
26. Huang da W., et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37(1):1-13.
27. Huang da W., et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4(1):44-57.
28. Huang X.P., et al. Negative implication of C-MYC as an amplification target in esophageal cancer. Cancer Genet. Cytogenet. 2006, 165(1):20-24.
29. Hung R.J., et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162(10):925-942.
30. Jemal A., et al. Global cancer statistics. CA Cancer J. Clin. 2011, 61(2):69-90.
31. Ju H., et al. A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression. Neoplasia 2009, 11(12):1340-1347.
32. Ju H., et al. Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer. J. Cancer Res. Clin. Oncol. 2010, 136(2):195-201.
33. Kalish R.S. Antigen processing: the gateway to the immune response. J. Am. Acad. Dermatol. 1995, 32(4):640-652.
34. Koo C.Y., et al. FOXM1: from cancer initiation to progression and treatment. Biochim. Biophys. Acta 2012, 1819(1):28-37.
35. Kooperberg C., et al. Risk prediction using genome-wide association studies. Genet. Epidemiol. 2010, 34(7):643-652.
36. Lichtenstein P., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 2000, 343(2):78-85.
37. Ligers A., et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2001, 2(3):145-152.
38. Long J., et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet. 2010, 6(6):e1001002.
39. Lu J., et al. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J. 2009, 23(10):3459-3469.
40. Mahmoudi T., et al. Vitamin D receptor gene ApaI polymorphism is associated with susceptibility to colorectal cancer. Dig. Dis. Sci. 2010, 55(7):2008-2013.
41. Mapara M.Y., Sykes M. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J. Clin. Oncol. 2004, 22(6):1136-1151.
42. Matsuo K., et al. Association between an 8q24 locus and the risk of colorectal cancer in Japanese. BMC Cancer 2009, 9:379.
43. Mita Y., et al. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers. J. Cancer Res. Clin. Oncol. 2010, 136(2):249-259.
44. Moore K.W., et al. Interleukin-10. Annu. Rev. Immunol. 1993, 11:165-190.
45. Moreno V., et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin. Cancer Res. 2006, 12(7 Pt 1):2101-2108.
46. Moriarty T.J., et al. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization. Mol. Biol. Cell 2005, 16(7):3152-3161.
47. Okabayashi K., et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am. J. Gastroenterol. 2012, 107:1175-1185.
48. Palka H.L., et al. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 2003, 278(8):5728-5735.
49. Park J.H., et al. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J. Clin. Oncol. 2012, 30(17):2157-2162.
50. Powell S.M., et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992, 359(6392):235-237.
51. Qi P., et al. CTLA-4+49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int. J. Colorectal Dis. 2010, 25(1):39-45.
52. Stacey S.N., et al. New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet. 2009, 41(8):909-914.
53. Stoner M., et al. Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins. J. Biol. Chem. 2000, 275(30):22769-22779.
54. Sugimoto M., et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J. Gastroenterol. Hepatol. 2007, 22(9):1443-1449.
55. Taiwan Cancer Registry, D.o.H., Executive Yuan, Taiwan Cancer registry annual report in Taiwan 2012.
56. Takata R., et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat. Genet. 2010, 42(9):751-754.
57. Tangrea J., et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997, 8(4):615-625.
58. Tenesa A., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet. 2008, 40(5):631-637.
59. Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997, 7(4):445-450.
60. Tomlinson I., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 2007, 39(8):984-988.
61. Walczak A., et al. The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer. DNA Cell Biol. 2012.
62. Wang X.Q., et al. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma. Clin. Cancer Res. 2006, 12(17):5248-5252.
63. Weir B.S., et al. Measures of human population structure show heterogeneity among genomic regions. Genome Res. 2005, 15(11):1468-1476.
64. Wokolorczyk D., et al. A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res. 2008, 68(23):9982-9986.
65. Wrensch M., et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 2009, 41(8):905-908.
66. Xu D., et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 1998, 188(8):1485-1492.
67. Yamamoto M., et al. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J. Biol. Chem. 1997, 272(19):12492-12494.
68. Yang H., et al. A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a southwestern Chinese population. Cancer Epidemiol. Biomarkers Prev. 2009, 18(9):2522-2527.
69. Yuan T., et al. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population. Cancer Epidemiol. 2011, 35(2):170-174.
70. Zhang P., et al. Gene expression profiles in the PC-3 human prostate cancer cells induced by NKX3.1. Mol. Biol. Rep. 2010, 37(3):1505-1512.